Top Markets
Coin of the day
ZyVersa Therapeutics, Inc. ZyVersa Therapeutics, Inc.

ZyVersa Therapeutics, Inc.

ZVSA
Peringkat dalam Saham #38791
ZyVersa Therapeutics, Inc. is a biopharmaceutical firm in its clinical... ZyVersa Therapeutics, Inc. is a biopharmaceutical firm in its clinical development phase, dedicated to advancing and commercializing therapies for renal (kidney) and inflammatory disorders. The company's pipeline prominently features VAR 200, a cholesterol efflux modulator aimed at addressing kidney diseases such as focal segmental glomerulosclerosis, Alport syndrome, and diabetic kidney disease. Furthermore, ZyVersa is advancing IC 100, a pioneering inflammasome ASC inhibitor positioned to tackle a wide array of inflammatory conditions. The company maintains its corporate headquarters in Weston, Florida.
Harga Saham
$0.099
Kapitalisasi Pasar
$801.50K
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
-34.44%
Negara
US
Perdagangan ZyVersa Therapeutics, Inc. (ZVSA)

Kategori

Harga ZVSA dengan kapitalisasi pasar B
ZyVersa Therapeutics, Inc. ZyVersa Therapeutics, Inc.
ZVSA
$0.099
Kapitalisasi pasar dari ZyVersa Therapeutics, Inc.(ZVSA)
Kapitalisasi Pasar: $801.50K
Per August 2026, ZyVersa Therapeutics, Inc. memiliki kapitalisasi pasar sebesar $801.50K. Ini menjadikan ZyVersa Therapeutics, Inc. sebagai perusahaan 38791st paling bernilai di dunia menurut data kami. Kapitalisasi pasar adalah nilai total saham beredar dari perusahaan publik dan biasanya digunakan untuk mengukur seberapa besar nilai sebuah perusahaan.
Riwayat kapitalisasi pasar ZyVersa Therapeutics, Inc. dari 2022 hingga 2026
ZVSA dibandingkan dengan 5 teratas stocks paling populer
Harga ZVSA Aset B Pasar B Hasil
ZyVersa Therapeutics, Inc. ZyVersa Therapeutics, Inc.
$673,582 $801.50K
$5.453T +680,385,253.80%
ZyVersa Therapeutics, Inc. ZyVersa Therapeutics, Inc.
$554,112 $801.50K
$4.486T +559,709,165.37%
ZyVersa Therapeutics, Inc. ZyVersa Therapeutics, Inc.
$514,230 $801.50K
$4.163T +519,423,671.96%
ZyVersa Therapeutics, Inc. ZyVersa Therapeutics, Inc.
$455,938 $801.50K
$3.691T +460,543,806.96%
ZyVersa Therapeutics, Inc. ZyVersa Therapeutics, Inc.
$351,165 $801.50K
$2.843T +354,712,320.17%